May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
TGFß1 Activates p38 Pathway in Primary Human Corneal Epithelial Cells
Author Affiliations & Notes
  • X.Q. Guo
    Schepens Eye Research Institute, Boston, MA
    Department of Ophthalmology, Harvard Medical School, Boston, MA
  • A.E. K. Hutcheon
    Schepens Eye Research Institute, Boston, MA
    Department of Ophthalmology, Harvard Medical School, Boston, MA
  • J.D. Zieske
    Schepens Eye Research Institute, Boston, MA
    Department of Ophthalmology, Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships  X.Q. Guo, None; A.E.K. Hutcheon, None; J.D. Zieske, None.
  • Footnotes
    Support  NIH Grant RO1 EY05665 to JDZ
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1453. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X.Q. Guo, A.E. K. Hutcheon, J.D. Zieske; TGFß1 Activates p38 Pathway in Primary Human Corneal Epithelial Cells . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1453.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: TGFß1 has been observed to transduce its signal through Smad proteins as well as by activating the p38 pathway in non–corneal tissues. We have previously observed that TGFß1 stimulates the translocation of Smad proteins in primary human corneal epithelium, and in the current investigation, we examined if TGFß1 also stimulates the p38 pathway. Methods: Primary human corneal epithelial cells were cultured in T75 flasks in Keratinocyte–SFM with EGF and pituitary extract until they reached ∼70% confluence. Upon reaching 70% confluence, the cells were rinsed with PBS and cultured overnight in serum–free media (Keratinocyte–SFM without EGF and pituitary extract = basic medium). The next day, the cells were incubated with basic medium plus 2ng/ml of TGFß1 for 5, 10, 15, or 30 minutes, 1, 2, 4, 8, or 24 hours. Cells in basic medium only served as a control. After the appropriate time, the cells were harvested and lysed for western blotting. Equal amounts of protein per sample were loaded onto a 12% SDS–PAGE, electrophoresed and transferred to a membrane. Western blotting was performed with anti–p38 and anti–phospho(p)–p38. Results: After treating primary human corneal epithelial cells with TGFß1, the levels of p38 remain unchanged. However, the active form of p38 (p–p38) appears to increase within 5 minutes of treatment with TGFß1 (5.3 fold enhancement). The level of p–p38 then decreases by 15 minutes, increases again by 1 hour, and continues to increase until 24 hours (10.0 fold enhancement). Conclusions: TGFß1 appears to stimulate the p38 pathway with both an immediate and long–term response. Thus, TGFß1 may activate both the Smad and p38 pathways in human corneal epithelial cells.

Keywords: growth factors/growth factor receptors • cornea: epithelium • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×